Once-daily solifenacin succinate or extended-release tolterodine for overactive bladder syndrome?

被引：0

作者：

Wyndaele, JJ ^{[1
]}

机构：

[1] Univ Antwerp, Dept Urol, Edegem, Belgium

来源：

NATURE CLINICAL PRACTICE UROLOGY | 2006年 / 3卷 / 04期

关键词：

antimuscarinic; overactive bladder syndrome; solifenacin succinate; tolterodine;

D O I：

10.1038/ncpuro0440

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：184 / 185

页数：2

共 50 条

[1] Once-daily solifenacin succinate or extended-release tolterodine for overactive bladder syndrome?
Jean Jacques Wyndaele
[J]. Nature Clinical Practice Urology, 2006, 3 : 184 - 185
[2] Treatment of overactive bladder with once-daily extended-release tolterodine or oxybutynin: The antimuscarinic clinical effectiveness trial (ACET)
Sussman, D
Garely, A
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (04) : 177 - 184
[3] Tolterodine extended-release for overactive bladder
Chung, Doreen E.
Te, Alexis E.
[J]. EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (13) : 2181 - 2194
[4] Tolterodine once-daily in treatment of the overactive bladder
Appell, RA
Anderson, R
Diokno, AC
Dmochowski, R
Staskin, D
[J]. UROLOGY, 2001, 58 (05) : 830 - 831
[5] Efficacy, safety, and tolerability of extended-release once-daily tolterodine treatment for overactive bladder in older versus younger patients
Zinner, NR
Mattiasson, A
Stanton, SL
[J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2002, 50 (05) : 799 - 807
[6] A cost effectiveness analysis of solifenacin compared with extended-release tolterodine for the treatment of overactive bladder
Kang, H. H.
Bae, J. Y.
Park, S. Y.
Sohn, H. S.
[J]. VALUE IN HEALTH, 2007, 10 (06) : A319 - A319
[7] Once-daily, extended-release formulations of antimuscarinic agents in the treatment of overactive bladder: A review
Rovner, ES
Wein, AJ
[J]. EUROPEAN UROLOGY, 2002, 41 (01) : 6 - 14
[8] Tolterodine once-daily in treatment of the overactive bladder - Reply
Van Kerrebroeck, P
[J]. UROLOGY, 2001, 58 (05) : 831 - 832
[9] A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: Results of the STAR trial
Chapple, CR
Martinez-Garcia, R
Selvaggi, L
Toozs-Hobson, P
Warnack, W
Drogendijk, T
Wright, DM
Bolodeoku, J
[J]. EUROPEAN UROLOGY, 2005, 48 (03) : 464 - 470
[10] Safety and Efficacy of Once-Daily Trospium Chloride Extended-release in Male Patients With Overactive Bladder
MacDiarmid, Scott A.
Ellsworth, Pamela I.
Ginsberg, David A.
Oefelein, Michael G.
Sussman, David O.
[J]. UROLOGY, 2011, 77 (01) : 24 - 29

← 1 2 3 4 5 →